Literature DB >> 1348029

Polymorphism of human immunoglobulin VH4 germ-line genes.

N P Weng1, J G Snyder, L Y Yu-Lee, D M Marcus.   

Abstract

The human immunoglobulin VH4 gene family is thought to contain approximately 10 germ-line genes and to exhibit little polymorphism. We report here an analysis of VH4 germ-line genes that were amplified from DNA of two unrelated individuals. Ten unique (non-repetitive) sequences were obtained from individual A and 11 from individual B. Nine of these sequences represent new germ-line genes, and 8/9 exhibit only 89%-96% similarity to genes identified previously. Subsets of VH4 genes displayed distinctive nucleotide motifs that account for most of the differences between them. This observation suggests that diversity in the VH4 gene family arose from the acquisition of blocks of nucleotides, rather than by accumulation of point mutations. These nucleotide blocks could have been acquired by gene conversion or by homologous recombination. All of the VH4 genes have a potential N-linked glycosylation site at Asn 60, and some genes encode a second site at Asn 52. The VH4 gene family is larger and more polymorphic than appreciated previously. Immunoglobulin gene polymorphism may make a significant contribution to hereditary variations in the immune response and to the genetic predisposition to autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348029     DOI: 10.1002/eji.1830220430

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Direct detection of insertion/deletion polymorphisms in an autosomal region by analyzing high-density markers in individual spermatozoa.

Authors:  Sreemanta Pramanik; Honghua Li
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

Review 2.  Antibody variable region glycosylation: biochemical and clinical effects.

Authors:  A Wright; S L Morrison
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.

Authors:  E W Schettino; A Cerutti; N Chiorazzi; P Casali
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

4.  Ethnic differences of polymorphism of an immunoglobulin VH3 gene.

Authors:  E H Sasso; J H Buckner; L A Suzuki
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 5.  The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement.

Authors:  B Chang; P Casali
Journal:  Immunol Today       Date:  1994-08

Review 6.  Human innate B cells: a link between host defense and autoimmunity?

Authors:  Eric C B Milner; Jennifer Anolik; Amedeo Cappione; Iñaki Sanz
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

7.  Molecular study of an IgG1kappa cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia.

Authors:  H R Galea; F Bridoux; J-C Aldigier; F Paraf; D Bordessoule; G Touchard; M Cogné
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

8.  Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells.

Authors:  X Mariette; Y Levy; M L Dubreuil; L Intrator; F Danon; J C Brouet
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

9.  Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase.

Authors:  N Harindranath; H Ikematsu; A L Notkins; P Casali
Journal:  Int Immunol       Date:  1993-12       Impact factor: 4.823

10.  Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection.

Authors:  H Ikematsu; M T Kasaian; E W Schettino; P Casali
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.